Epigenetic memory gained by priming with osteogenic induction medium improves osteogenesis and other properties of mesenchymal stem cells

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Rui, Yunfeng ^a,b   Xu, Liangliang ^b   Chen, Rui ^c   Zhang, Ting ^b   Lin, Sien ^b   Hou, Yonghui ^b   Liu, Yang ^b   Meng, Fanbiao ^a   Liu, Zhenqing ^c   Ni, Ming ^b,e   Tsang, Kam Sze ^c   Yang, Fuyuan ^c   Wang, Chen ^a   Chang Chan, Hsiao ^c,d   Jiang, Xiaohua ^c,d   Li, Gang ^b,c,d  

^a SOUTHEAST UNIVERSITY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d Chinese University of Hong Kong   (Hong Kong)

^e CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

NANOG PROTEIN, RAT; OCTAMER TRANSCRIPTION FACTOR 4; SMALL INTERFERING RNA; SOX2 PROTEIN, RAT; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX;

ADIPOGENESIS; ANIMAL; BIOSYNTHESIS; BONE DEVELOPMENT; BONE REGENERATION; CELL CULTURE; CELL DEDIFFERENTIATION; CELL MOTION; CELL PROLIFERATION; CELL SURVIVAL; CHONDROGENESIS; DNA METHYLATION; GENETIC EPIGENESIS; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; MOUSE; NUDE MOUSE; PHYSIOLOGY; PROMOTER REGION; RAT; RNA INTERFERENCE;

ADIPOGENESIS; ANIMALS; BONE REGENERATION; CELL DEDIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CHONDROGENESIS; DNA METHYLATION; EPIGENESIS, GENETIC; MESENCHYMAL STROMAL CELLS; MICE; MICE, NUDE; NANOG HOMEOBOX PROTEIN; OCTAMER TRANSCRIPTION FACTOR-3; OSTEOGENESIS; PROMOTER REGIONS, GENETIC; RATS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SOXB1 TRANSCRIPTION FACTORS; TRANSCRIPTION FACTORS;

EID: 84930933147     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep11056     Document Type: Article

References (52)

1. Dimitriou, R., Jones, E., McGonagle, D. & Giannoudis, P. V. Bone regeneration: current concepts and future directions. BMC Med 9, 66 (2011).
2. Kon, E. et al. Bone regeneration with mesenchymal stem cells. Clin Cases Miner Bone Metab 9, 24-27 (2012).
3. Parekkadan, B. & Milwid, J. M. Mesenchymal stem cells as therapeutics. Annu Rev Biomed Eng 12, 87-117 (2010).
4. Hicks, A. U. et al. Transplantation of human embryonic stem cell-derived neural precursor cells and enriched environment after cortical stroke in rats: cell survival and functional recovery. Eur J Neurosci 29, 562-574 (2009).
5. Li, Y. et al. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology 59, 514-523 (2002).
6. Swanger, S. A., Neuhuber, B., Himes, B. T., Bakshi, A. & Fischer, I. Analysis of allogeneic and syngeneic bone marrow stromal cell graft survival in the spinal cord. Cell Transplant 14, 775-786 (2005).
7. Chen, J. et al. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 32, 2682-2688 (2001).
8. Jiang, Y. et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418, 41-49 (2002).
9. Joshi, C. V. & Enver, T. Plasticity revisited. Curr Opin Cell Biol 14, 749-755 (2002).
10. Petersen, B. E. et al. Bone marrow as a potential source of hepatic oval cells. Science 284, 1168-1170 (1999).
11. Woodbury, D., Schwarz, E. J., Prockop, D. J. & Black, I. B. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 61, 364-370 (2000).
12. Liu, Y. et al. Switching from bone marrow-derived neurons to epithelial cells through dedifferentiation and translineage redifferentiation. Cell Biol Int 34, 1075-1083 (2010).
13. Poloni, A. et al. Human dedifferentiated adipocytes show similar properties to bone marrow-derived mesenchymal stem cells. Stem Cells 30, 965-974 (2012).
14. Liu, Y. et al. Dedifferentiation-reprogrammed mesenchymal stem cells with improved therapeutic potential. Stem cells 29, 2077-2089 (2011).
15. Uccelli, A., Moretta, L. & Pistoia, V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 8, 726-736 (2008).
16. Blondheim, N. R. et al. Human mesenchymal stem cells express neural genes, suggesting a neural predisposition. Stem Cells Dev 15, 141-164 (2006).
17. Barzilay, R., Melamed, E. & Offen, D. Introducing transcription factors to multipotent mesenchymal stem cells: making transdifferentiation possible. Stem Cells 27, 2509-2515 (2009).
18. Spivakov, M. & Fisher, A. G. Epigenetic signatures of stem-cell identity. Nat Rev Genet 8, 263-271 (2007).
19. Papp, B. & Plath, K. Epigenetics of reprogramming to induced pluripotency. Cell 152, 1324-1343 (2013).
20. Marks, H. & Stunnenberg, H. G. Transcription regulation and chromatin structure in the pluripotent ground state. Biochim Biophys Acta 1839, 129-137 (2014).
21. Liu, T. M. et al. Effects of ectopic Nanog and Oct4 overexpression on mesenchymal stem cells. Stem Cells Dev 18, 1013-1022 (2009).
22. Go, M. J., Takenaka, C. & Ohgushi, H. Forced expression of Sox2 or Nanog in human bone marrow derived mesenchymal stem cells maintains their expansion and differentiation capabilities. Exp Cell Res 314, 1147-1154 (2008).
23. Ye, L. et al. Histone demethylases KDM4B and KDM6B promotes osteogenic differentiation of human MSCs. Cell Stem Cell 11, 50-61 (2012).
24. Boquest, A. C., Noer, A. & Collas, P. Epigenetic programming of mesenchymal stem cells from human adipose tissue. Stem Cell Rev 2, 319-329 (2006).
25. Bernstein, B. E. et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125, 315-326 (2006).
26. Mikkelsen, T. S. et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448, 553-560 (2007).
27. Zhao, X. D. et al. Whole-genome mapping of histone H3 Lys4 and 27 trimethylations reveals distinct genomic compartments in human embryonic stem cells. Cell Stem Cell 1, 286-298 (2007).
28. Pan, G. et al. Whole-genome analysis of histone H3 lysine 4 and lysine 27 methylation in human embryonic stem cells. Cell Stem Cell 1, 299-312 (2007).
29. Leu, Y. W., Huang, T. H. & Hsiao, S. H. Epigenetic reprogramming of mesenchymal stem cells. Adv Exp Med Biol 754, 195-211 (2013).
30. Hsiao, S. H. et al. DNA methylation of the Trip10 promoter accelerates mesenchymal stem cell lineage determination. Biochem Biophys Res Commun 400, 305-312 (2010).
31. Boyer, L. A. et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122, 947-956 (2005).
32. Tsai, C. C., Su, P. F., Huang, Y. F., Yew, T. L. & Hung, S. C. Oct4 and Nanog directly regulate Dnmt1 to maintain self-renewal and undifferentiated state in mesenchymal stem cells. Mol Cell 47, 169-182 (2012).
33. Greer, E. L. et al. Members of the H3K4 trimethylation complex regulate lifespan in a germline-dependent manner in C. elegans. Nature 466, 383-387 (2010).
34. Bonasio, R., Tu, S. & Reinberg, D. Molecular signals of epigenetic states. Science 330, 612-616 (2010).
35. Bannister, A. J. & Kouzarides, T. Regulation of chromatin by histone modifications. Cell Res 21, 381-395 (2011).
36. Bais, M. V. et al. Role of Nanog in the maintenance of marrow stromal stem cells during post natal bone regeneration. Biochem Biophys Res Commun 417, 211-216 (2012).
37. Greco, S. J., Liu, K. & Rameshwar, P. Functional similarities among genes regulated by OCT4 in human mesenchymal and embryonic stem cells. Stem Cells 25, 3143-3154 (2007).
38. Kohler, E. E. et al. Low-Dose 6-Bromoindirubin-3'-oxime Induces Partial Dedifferentiation of Endothelial Cells to Promote Increased Neovascularization. Stem Cells 32, 1538-1552 (2014).
39. Reyes-Aguirre, L. I. et al. Glutamate-induced epigenetic and morphological changes allow rat Muller cell dedifferentiation but not further acquisition of a photoreceptor phenotype. Neuroscience 254, 347-360 (2013).
40. Yannarelli, G. et al. Brief report: The potential role of epigenetics on multipotent cell differentiation capacity of mesenchymal stromal cells. Stem Cells 31, 215-220 (2013).
41. Guenther, M. G. et al. Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells. Cell Stem Cell 7, 249-257 (2010).
42. Hemming, S. et al. EZH2 and KDM6A act as an epigenetic switch to regulate mesenchymal stem cell lineage specification. Stem Cells 32, 802-815 (2014).
43. Musri, M. M. et al. Histone demethylase LSD1 regulates adipogenesis. J Biol Chem 285, 30034-30041 (2010).
44. Dong, R., Yao, R., Du, J., Wang, S. & Fan, Z. Depletion of histone demethylase KDM2A enhanced the adipogenic and chondrogenic differentiation potentials of stem cells from apical papilla. Exp Cell Res 319, 2874-2882 (2013).
45. Zhu, Y. et al. Alteration of Histone Acetylation Pattern during Long-Term Serum-Free Culture Conditions of Human Fetal Placental Mesenchymal Stem Cells. PLoS One 10, e0117068 (2015).
46. Lynch P.J., T. E., McGinnis, K., Rovira Gonzalez, Y. I., Lo Surdo, J., Bauer, S. R. & Hursh, D. A. Chromatin changes at the PPAR-γ 2 promoter during bone marrow-derived multipotent stromal cell culture correlate with loss of gene activation potential. Stem Cells [Epub ahead of print] (2015).
47. Diaz, P., Cuevas, F. & Peralta, O. A. GFP labelling and epigenetic enzyme expression of bone marrow-derived mesenchymal stem cells from bovine foetuses. Res Vet Sci 99, 120-128 (2015).
48. Outchkourov, N. S. et al. Balancing of histone H3K4 methylation states by the Kdm5c/SMCX histone demethylase modulates promoter and enhancer function. Cell Rep 3, 1071-1079 (2013).
49. Xu, L. L. et al. Cellular retinol-binding protein 1 (CRBP-1) regulates osteogenenesis and adipogenesis of mesenchymal stem cells through inhibiting RXR alpha-induced beta-catenin degradation. Int J Biochem Cell B 44, 612-619 (2012).
50. Kutner, R. H., Zhang, X. Y. & Reiser, J. Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors. Nat Protoc 4, 495-505 (2009).
51. Zinn, R. L., Pruitt, K., Eguchi, S., Baylin, S. B. & Herman, J. G. hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site. Cancer Res 67, 194-201 (2007).
52. Rui, Y. F., Lui, P. P., Lee, Y. W. & Chan, K. M. Higher BMP receptor expression and BMP-2-induced osteogenic differentiation in tendon-derived stem cells compared with bone-marrow-derived mesenchymal stem cells. Int Orthop 36, 1099-1107 (2012).